ACPA |
Anti-cyclic citrullinated peptide antibodies |
ACR |
American College of Rheumatology |
AEs |
Adverse events |
bDMARDs |
Biological disease-modifying anti-rheumatic drugs |
CDAI |
Clinical disease activity index |
CI |
Confidence interval |
CRB |
Certified review board |
CRP |
C-reactive protein |
csDMARDs |
Conventional synthetic disease-modifying antirheumatic drugs |
DAS28 |
Disease Activity Score—28 |
ELISA |
Enzyme-Linked Immuno Sorbent Assay |
ESR |
Erythrocyte sedimentation rate |
EULAR |
European League Against Rheumatism |
FAS |
Full analysis set |
GLOESS |
Global OMERACT-EULAR Synovitis Score |
GS |
Gray scale |
HAQ-DI |
Health Assessment Questionnaire–Disability Index |
IL |
Interleukin |
IP |
Interphalangeal |
IQR |
Interquartile range |
JAK |
Janus kinase |
JCR |
Japan College of Rheumatology |
MCP |
Metacarpophalangeal |
MMP-3 |
Matrix metalloproteinase-3 |
MSUS |
Musculoskeletal ultrasound |
MTX |
Methotrexate |
OMERACT |
Outcome Measures in Rheumatology |
PD |
Power Doppler |
PIP |
Proximal interphalangeal |
PSL |
Prednisolone |
RA |
Rheumatoid arthritis |
RF |
Rheumatoid factor |
RP |
Reference product |
SDAI |
Simplified disease activity index |
SRM |
Standardized response mean |
TNF |
Tumor necrosis factor |
T2T |
treat-to-targe |
vdH-mTSS |
Van der Heijde-modified total Sharp score |